Skip to main content
OpenTrials
Completed

NCT Number: NCT03678558

Oocyte Vitrification Aided With Cytochalasin B

Using the cytoskeleton Stabilizer the Cytochalasin B would improve the outcome of oocyte vitrification.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Urogenital Diseases

Age range

18 year–42 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

IbnSina IVF Center, IbnSina Hospital

Sohag, 12345, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • indication for oocyte vitrification

Exclusion criteria

-

Treatment and study plan

Cytochalasin B supplemented vitrification medium

Other

Vitrification of human oocyte in medium supplemented with Cytochalasin B

Primary outcomes

  1. survival after thawing

    Time frame: 6 days of culture

Secondary outcomes

  1. fertilization rate

    Time frame: 6 days of culture

  2. Rates of blastocyst formation and quality

    Time frame: 6 days of culture

    Number of formed blastocyst and blastocyst with high-quality per fertilized oocytes

  3. embryo utilisation rate

    Time frame: 6 days of culture

  4. clinical pregnancy rate

    Time frame: three months

  5. ongoing pregnancy rate

    Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Ibn Sina Hospital

Other Gov

Collaborators

  • Banoon IVF Center

Registry information

Official study title

Cytochalasin B for Oocyte Vitrification

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Sep 19, 2018
Registry last updated
Aug 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.